NF-κB-mediated adaptive resistance to ionizing radiation

Free Radical Biology and Medicine

Volumn 44, Issue 1, 2008, Pages 1-13

  Mokim Ahmed, Kazi ^a   Li, Jian Jian ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Adaptive radiation resistance; Free radicals; Ionizing radiation; NF B; Signal transduction

Indexed keywords

ATM PROTEIN; CYCLIN B1; EPIDERMAL GROWTH FACTOR RECEPTOR 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE;

BREAST CANCER; CANCER CELL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RESISTANCE; CANCER SURVIVAL; HUMAN; IONIZING RADIATION; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIVITY; REVIEW;

ANIMALS; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, RADIATION; GENES, ERBB-2; HUMANS; NEOPLASMS; NEOPLASTIC STEM CELLS; NF-KAPPA B; RADIATION TOLERANCE; RADIATION, IONIZING; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 36248973110     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2007.09.022     Document Type: Review

References (162)

1. Kim J.J., and Tannock I.F. Repopulation of cancer cells during therapy: an important cause of treatment failure. Nat. Rev., Cancer 5 (2005) 516-525
2. Stecca C., and Gerber G.B. Adaptive response to DNA-damaging agents: a review of potential mechanisms. Biochem. Pharmacol. 55 (1998) 941-951
3. Olivieri G., Bodycote J., and Wolff S. Adaptive response of human lymphocytes to low concentrations of radioactive thymidine. Science 223 (1994) 594-597
4. Kelsey K.T., Memisoglu A., Frenkel D., and Liber H.L. Human lymphocytes exposed to low doses of X-rays are less susceptible to radiation-induced mutagenesis. Mutat. Res. 263 (1991) 197-201
5. Feinendegen L.E., Bond V.P., Sondhaus C.A., and Muehlensiepen H. Radiation effects induced by low doses in complex tissue and their relation to cellular adaptive responses. Mutat. Res. 358 (1996) 199-205
6. Muckerheide J. It's time to tell the truth about the health benefits of low-dose radiation. 21st Century Sci. Technol. (2000) 43-45 Summer
7. Bhattacharjee D. Role of radioadaptation on radiation-induced thymic lymphoma in mice. Mutat. Res. 358 (1996) 231-235
8. Liu S.Z., Cai L., and Sun S.Q. Induction of a cytogenetic adaptive response by exposure of rabbits to very low dose-rate gamma-radiation. Int. J. Radiat. Biol. 62 (1992) 187-190
9. Shadley J.D., and Wolff S. Very low doses of X-rays can cause human lymphocytes to become less susceptible to ionizing radiation. Mutagenesis 2 (1987) 95-96
10. Begg A.C., Hofland I., and Kummermehr J. Tumour cell repopulation during fractionated radiotherapy: correlation between flow cytometric and radiobiological data in three murine tumours. Eur. J. Cancer 27 (1991) 537-543
11. Rofstad E.K. Repopulation between radiation fractions in human melanoma xenografts. Int. J. Radiat. Oncol. Biol. Phys. 23 (1992) 63-68
12. Russell J., Wheldon T.E., and Stanton P.A. radioresistant variant derived from a human neuroblastoma cell line is less prone to radiation-induced apoptosis. Cancer Res. 55 (1995) 4915-4921
13. Robson T., Price M.E., Moore M.L., Joiner M.C., McKelvey-Martin V.J., McKeown S.R., and Hirst D.G. Increased repair and cell survival in cells treated with DIR1 antisense oligonucleotides: implications for induced radioresistance. Int. J. Radiat. Biol. 76 (2000) 617-623
14. Al-Hajj M., and Clarke M.F. Self-renewal and solid tumor stem cells. Oncogene 23 (2004) 7274-7282
15. Al-Hajj M., Becker M.W., Wicha M., Weissman I., and Clarke M.F. Therapeutic implications of cancer stem cells. Curr. Opin. Genet. Dev. 14 (2004) 43-47
16. Lapidot T., Pflumio F., Doedens M., Murdoch B., Williams D.E., and Dick J.E. Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. Science 255 (1992) 1137-1141
17. Dick J.E. Normal and leukemic human stem cells assayed in SCID mice. Semin. Immunol. 8 (1996) 197-206
18. Al-Hajj M. Cancer stem cells and oncology therapeutics. Curr. Opin. Oncol. 19 (2007) 61-64
19. Bao S., Wu Q., McLendon R.E., Hao Y., Shi Q., Hjelmeland A.B., Dewhirst M.W., Bigner D.D., and Rich J.N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444 (2006) 756-760
20. Phillips T.M., McBride W.H., and Pajonk F. The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J. Natl. Cancer Inst. 98 (2006) 1777-1785
21. Guo G., Yan-Sanders Y., Lyn-Cook B.D., Wang T., Tamae D., Ogi J., Khaletskiy A., Li Z., Weydert C., Longmate J.A., Huang T.T., Spitz D.R., Oberley L.W., and Li J.J. Manganese superoxide dismutase-mediated gene expression in radiation-induced adaptive responses. Mol. Cell. Biol. 23 (2003) 2362-2378
22. Ahmed K.M., Dong S., Fan M., and Li J.J. Nuclear factor-kappaB p65 inhibits mitogen-activated protein kinase signaling pathway in radioresistant breast cancer cells. Mol. Cancer Res. 4 (2006) 945-955
23. Sen R., and Baltimore D. Inducibility of kappa immunoglobulin enhancer-binding protein NF-kappa B by a posttranslational mechanism. Cell 47 (1986) 921-928
24. Nabel G.J., and Verma I.M. Proposed NF-kappa B/I kappa B family nomenclature. Genes Dev. 7 (1993) 2063
25. Kuriyan J., and Thanos D. Structure of the NF-kappa B transcription factor: a holistic interaction with DNA. Structure 3 (1995) 135-141
26. Ghosh G., van Duyne G., Ghosh S., and Sigler P.B. Structure of NF-kappa B p50 homodimer bound to a kappa B site. Nature 373 (1995) 303-310
27. Gossen M., Freundlieb S., Bender G., Muller G., Hillen W., and Bujard H. Transcriptional activation by tetracycline in mammalian cells. Science 268 (1995) 1766-1769
28. Verma I.M., Stevenson J.K., Schwarz E.M., Van Antwerp D., and Miyamoto S. Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev. 9 (1995) 2723-2735
29. Baeuerle P.A., and Henkel T. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12 (1994) 141-179
30. Piette J., Piret B., Bonizzi G., Schoonbroodt S., Merville M.P., Legrand-Poels S., and Bours V. Multiple redox regulation in NF-kappaB transcription factor activation. Biol. Chem. 378 (1997) 1237-1245
31. Sigala J.L.D., Bottero V., Young D.B., Shevchenko A., Mercurio F., and Verma I.M. Activation of transcription factor NF-κB requires ELKS, an IκB kinase regulatory subunit. Science 304 (2004) 1963-1967
32. Orlowski R.Z., and Baldwin Jr. A.S. NF-kappaB as a therapeutic target in cancer. Trends Mol. Med. 8 (2002) 385-389
33. Brach M.A., Hass R., Sherman M.L., Gunji H., Weichselbaum R., and Kufe D. Ionizing radiation induces expression and binding activity of the nuclear factor kappa B. J. Clin. Invest. 88 (1991) 691-695
34. Tang G., Minemoto Y., Dibling B., Purcell N.H., Li Z., Karin M., and Lin A. Inhibition of JNK activation through NF-kappaB target genes. Nature 414 (2001) 313-317
35. Chen X., Shen B., Xia L., Khaletzkiy A., Chu D., Wong J.Y., and Li J.J. Activation of nuclear factor kappaB in radioresistance of TP53-inactive human keratinocytes. Cancer Res. 62 (2002) 1213-1221
36. Herscher L.L., Cook J.A., Pacelli R., Pass H.I., Russo A., and Mitchell J.B. Principles of chemoradiation: theoretical and practical considerations. Oncology 13 (1999) 11-22
37. Pajonk F., Pajonk K., and McBride W.H. Inhibition of NF-kappaB, clonogenicity, and radiosensitivity of human cancer cells. J. Natl. Cancer Inst. 91 (1999) 1956-1960
38. Flynn Jr. V., Ramanitharan A., Moparty K., Davis R., Sikka S., Agrawal K.C., and Abdel-Mageed A.B. Adenovirus-mediated inhibition of NF-kappaB confers chemo-sensitization and apoptosis in prostate cancer cells. Int. J. Oncol. 23 (2003) 317-323
39. Fan M., Ahmed K.M., Coleman M.C., Spitz D.R., and Li J.J. NF-kappaB and MnSOD mediate adaptive radioresistance in low dose irradiated mouse skin epithelial cells. Cancer Res. 67 (2007) 3220-3228
40. Li Z., Xia L., Lee M.L., Khaletskiy A., Wang J., Wong J.Y.C., and Li J.J. Effector genes altered in MCF-7 human breast cancer cells after exposure to fractionated ionizing radiation. Radiat. Res. 155 (2001) 543-553
41. Ahmed K.M., Cao N., and Li J.J. HER-2 and NF-kappaB as the targets for therapy-resistant breast cancer. Anticancer Res. 26 (2006) 4235-4243
42. Meyn M.S. Ataxia-telangiectasia and cellular responses to DNA damage. Cancer Res. 55 (1995) 5991-6001
43. Guo G., Wang T., Gao Q., Tamae D., Wong P., Chen T., Chen W.C., Shively J.E., Wong J.Y., and Li J.J. Expression of ErbB2 enhances radiation-induced NF-kappaB activation. Oncogene 23 (2004) 535-545
44. Hacker H., and Karin M. Regulation and function of IKK and IKK-related kinases. Sci. STKE (2006) re13
45. Senftleben U., Cao Y., Xiao G., Greten F.R., Krahn G., Bonizzi G., Chen Y., Hu Y., Fong A., Sun S.C., and Karin M. Activation by IKKalpha of a second, evolutionarily conserved, NF-kappa B signaling pathway. Science 293 (2001) 1495-1499
46. Chen J.-Y., Penco S., Ostrowski J., Balaguer P., Pons M., Starrett J.E., Reczek P., Chambon P., and Gronemeyer H. RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation. EMBO J. 14 (1995) 1187-1197
47. Baeuerle P.A., Rupec R.A., and Pahl H.L. Reactive oxygen intermediates as second messengers of a general pathogen response. Pathol. Biol. (Paris) 44 (1996) 29-35
48. Ben-Neriah Y. Regulatory functions of ubiquitination in the immune system. Nat. Immunol. 3 (2002) 20-26
49. Ghosh S., and Karin M. Missing pieces in the NF-kappaB puzzle. Cell 109 (2002) S81-S96 (Suppl.)
50. Gerritsen M.E., Williams A.J., Neish A.S., Moore S., Shi Y., and Collins T. CREB-binding protein/p300 are transcriptional coactivators of p65. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 2927-2932
51. Na S.Y., Lee S.K., Han S.J., Choi H.S., Im S.Y., and Lee J.W. Steroid receptor coactivator-1 interacts with the p50 subunit and coactivates nuclear factor kappaB-mediated transactivations. J. Biol. Chem. 273 (1998) 10831-10834
52. Sheppard K.A., Rose D.W., Haque Z.K., Kurokawa R., McInerney E., Westin S., Thanos D., Rosenfeld M.G., Glass C.K., and Collins T. Transcriptional activation by NF-kappaB requires multiple coactivators. Mol. Cell. Biol. 19 (1999) 6367-6378
53. Quivy V., Adam E., Collette Y., Demonte D., Chariot A., Vanhulle C., Berkhout B., Castellano R., de Launoit Y., Burny A., Piette J., Bours V., and Van Lint C. Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies. J. Virol. 76 (2002) 11091-11103
54. Adam E., Quivy V., Bex F., Chariot A., Collette Y., Vanhulle C., Schoonbroodt S., Goffin V., Nguyen T.L., Gloire G., Carrard G., Friguet B., De Launoit Y., Burny A., Bours V., Piette J., and Van Lint C. Potentiation of tumor necrosis factor-induced NF-kappa B activation by deacetylase inhibitors is associated with a delayed cytoplasmic reappearance of I kappa B alpha. Mol. Cell. Biol. 23 (2003) 6200-6209
55. Chen L., Fischle W., Verdin E., and Greene W.C. Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science 293 (2001) 1653-1657
56. Chen L.F., and Greene W.C. Regulation of distinct biological activities of the NF-kappaB transcription factor complex by acetylation. J. Mol. Med. 81 (2003) 549-557
57. Furia B., Deng L., Wu K., Baylor S., Kehn K., Li H., Donnelly R., Coleman T., and Kashanchi F. Enhancement of nuclear factor-kappa B acetylation by coactivator p300 and HIV-1 Tat proteins. J. Biol. Chem. 277 (2002) 4973-4980
58. Deng W.G., Zhu Y., and Wu K.K. Up-regulation of p300 binding and p50 acetylation in tumor necrosis factor-alpha-induced cyclooxygenase-2 promoter activation. J. Biol. Chem. 278 (2003) 4770-4777
59. Kiernan R., Bres V., Ng R.W., Coudart M.P., El Messaoudi S., Sardet C., Jin D.Y., Emiliani S., and Benkirane M. Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65. J. Biol. Chem. 278 (2003) 2758-2766
60. Chen L.F., Mu Y., and Greene W.C. Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB. EMBO J. 21 (2002) 6539-6548
61. Chen G., and Goeddel D.V. TNF-R1 signaling: a beautiful pathway. Science 296 (2002) 1634-1635
62. Ravi R., Bedi A., Fuchs E., and Bedi J. CD95 (Fas)-induced caspase-mediated proteolysis of NF-kappaB. Cancer Res. 58 (1998) 882-886
63. Barkett M., and Gilmore T.D. Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene 18 (1999) 6910-6924
64. Deveraux Q.L., and Reed J.C. IAP family proteins-suppressors of apoptosis. Genes Dev. 13 (1999) 239-252
65. Jung M., and Dritschilo A. NF-kappa B signaling pathway as a target for human tumor radiosensitization. Semin. Radiat. Oncol. 11 (2001) 346-351
66. Zhou D., Brown S.A., Yu T., Chen G., Barve S., Kang B.C., and Thompson J.S. A high dose of ionizing radiation induces tissue-specific activation of nuclear factor-kappaB in vivo. Radiat. Res. 151 (1999) 703-709
67. Guttridge D.C., Albanese C., Reuther J.Y., Pestell R.G., and Baldwin Jr. A.S. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol. Cell. Biol. 19 (1999) 5785-5799
68. Ozeki M., Tamae D., Hou D.X., Wang T., Lebon T., Spitz D.R., and Li J.J. Response of cyclin B1 to ionizing radiation: regulation by NF-kappaB and mitochondrial antioxidant enzyme MnSOD. Anticancer Res. 24 (2004) 2657-2663
69. Smirnov A.S., Ruzov A.S., Budanov A.V., Prokhortchouk A.V., Ivanov A.V., and Prokhortchouk E.B. High constitutive level of NF-kappaB is crucial for viability of adenocarcinoma cells. Cell Death Differ. 8 (2001) 621-630
70. Hallahan D.E., Spriggs D.R., Beckett M.A., Kufe D.W., and Weichselbaum R.R. Increased tumor necrosis factor alpha mRNA after cellular exposure to ionizing radiation. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 10104-10107
71. Chen M., Quintans J., Fuks Z., Thompson C., Kufe D.W., and Weichselbaum R.R. Suppression of Bcl-2 messenger RNA production may mediate apoptosis after ionizing radiation, tumor necrosis factor alpha, and ceramide. Cancer Res. 55 (1995) 991-994
72. Blonska M., You Y., Geleziunas R., and Lin X. Restoration of NF-kappaB activation by tumor necrosis factor alpha receptor complex-targeted MEKK3 in receptor-interacting protein-deficient cells. Mol. Cell. Biol. 24 (2004) 10757-10765
73. Rossi A., Kapahi P., Natoli G., Takahashi T., Chen Y., Karin M., and Santoro M.G. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase. Nature 403 (2000) 103-108
74. Osborn L., Kunkel S., and Nabel G.J. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 2336-2340
75. Baeuerle P.A., and Baltimore D. NF-kappa B: ten years after. Cell 87 (1996) 13-20
76. Inoue J., Ishida T., Tsukamoto N., Kobayashi N., Naito A., Azuma S., and Yamamoto T. Tumor necrosis factor receptor-associated factor (TRAF) family: adapter proteins that mediate cytokine signaling. Exp. Cell Res. 254 (2000) 14-24
77. Lee S.Y., and Choi Y. TRAF-interacting protein (TRIP): a novel component of the tumor necrosis factor receptor (TNFR)- and CD30-TRAF signaling complexes that inhibits TRAF2-mediated NF-kappaB activation. J. Exp. Med. 185 (1997) 1275-1285
78. Ling L., Cao Z., and Goeddel D.V. NF-kappaB-inducing kinase activates IKK-alpha by phosphorylation of Ser-176. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 3792-3797
79. Bradbury C.M., Markovina S., Wei S.J., Rene L.M., Zoberi I., Horikoshi N., and Gius D. Indomethacin-induced radiosensitization and inhibition of ionizing radiation-induced NF-kappaB activation in HeLa cells occur via a mechanism involving p38 MAP kinase. Cancer Res. 61 (2001) 7689-7696
80. Dent P., Yacoub A., Fisher P.B., Hagan M.P., and Grant S. MAPK pathways in radiation responses. Oncogene 22 (2003) 5885-5896
81. Wang T., Hu Y.C., Dong S., Fan M., Tamae D., Ozeki M., Gao Q., Gius D., and Li J.J. Co-activation of ERK, NF-kappaB, and GADD45beta in response to ionizing radiation. J. Biol. Chem. 280 (2005) 12593-12601
82. Javelaud D., and Besancon F. NF-kappa B activation results in rapid inactivation of JNK in TNF alpha-treated Ewing sarcoma cells: a mechanism for the anti-apoptotic effect of NF-kappa B. Oncogene 20 (2001) 4365-4372
83. Javelaud D., Wietzerbin J., Delattre O., and Besancon F. Induction of p21Waf1/Cip1 by TNFalpha requires NF-kappaB activity and antagonizes apoptosis in Ewing tumor cells. Oncogene 19 (2000) 61-68
84. Jin R., De Smaele E., Zazzeroni F., Nguyen D.U., Papa S., Jones J., Cox C., Gelinas C., and Franzoso G. Regulation of the gadd45beta promoter by NF-kappaB. DNA Cell Biol. 21 (2002) 491-503
85. Papa S., Zazzeroni F., Bubici C., Jayawardena S., Alvarez K., Matsuda S., Nguyen D.U., Pham C.G., Nelsbach A.H., Melis T., Smaele E.D., Tang W.J., D'Adamio L., and Franzoso G. Gadd45 beta mediates the NF-kappa B suppression of JNK signalling by targeting MKK7/JNKK2. Nat. Cell Biol. 6 (2004) 146-153
86. Tang D., Wu D., Hirao A., Lahti J.M., Liu L., Mazza B., Kidd V.J., Mak T.W., and Ingram A.J. ERK activation mediates cell cycle arrest and apoptosis after DNA damage independently of p53. J. Biol. Chem. 277 (2002) 12710-12717
87. 2-terminal kinase (JNK/SAPK) via a PKC-dependent pathway in human thyroid cells. Biochem. Biophys. Res. Commun. 244 (1998) 41-44
88. Persons D.L., Yazlovitskaya E.M., Cui W., and Pelling J.C. Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin. Clin. Cancer Res. 5 (1999) 1007-1014
89. Suzuki K., Kodama S., and Watanabe M. Extremely low-dose ionizing radiation causes activation of mitogen-activated protein kinase pathway and enhances proliferation of normal human diploid cells. Cancer Res. 61 (2001) 5396-5401
90. Reardon D.B., Contessa J.N., Mikkelsen R.B., Valerie K., Amir C., Dent P., and Schmidt-Ullrich R.K. Dominant negative EGFR-CD533 and inhibition of MAPK modify JNK1 activation and enhance radiation toxicity of human mammary carcinoma cells. Oncogene 18 (1999) 4756-4766
91. Mandic A., Viktorsson K., Heiden T., Hansson J., and Shoshan M.C. The MEK1 inhibitor PD98059 sensitizes C8161 melanoma cells to cisplatin-induced apoptosis. Melanoma Res. 11 (2001) 11-19
92. Smalley K.S., and Eisen T.G. Farnesyl thiosalicylic acid inhibits the growth of melanoma cells through a combination of cytostatic and pro-apoptotic effects. Int. J. Cancer 98 (2002) 514-522
93. Haffty B.G., Brown F., Carter D., and Flynn S. Evaluation of HER-2 neu oncoprotein expression as a prognostic indicator of local recurrence in conservatively treated breast cancer: a case-control study. Int. J. Radiat. Oncol. Biol. Phys. 35 (1996) 751-757
94. Hicks D.G., and Tubbs R.R. Assessment of the HER2 status in breast cancer by fluorescence in situ hybridization: a technical review with interpretive guidelines. Hum. Pathol. 36 (2005) 250-261
95. Carraway III K.L., Weber J.L., Unger M.J., Ledesma J., Yu N., Gassmann M., and Lai C. Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases. Nature 387 (1997) 512-516
96. Yu D., and Hung M.C. Overexpression of ErbB2 in cancer and ErbB2-targeting strategies. Oncogene 19 (2000) 6115-6121
97. Yarden Y., and Sliwkowski M.X. Untangling the ErbB signalling network. Nat. Rev., Mol. Cell Biol. 2 (2001) 127-137
98. Kurokawa H., and Arteaga C.L. Inhibition of erbB receptor (HER) tyrosine kinases as a strategy to abrogate antiestrogen resistance in human breast cancer. Clin. Cancer Res. 7 (2001) 4436s-4442s discussion 4411s-4412s
99. Galang C.K., Garcia-Ramirez J., Solski P.A., Westwick J.K., Der C.J., Neznanov N.N., Oshima R.G., and Hauser C.A. Oncogenic Neu/ErbB-2 increases ets, AP-1, and NF-kappaB-dependent gene expression, and inhibiting ets activation blocks Neu-mediated cellular transformation. J. Biol. Chem. 271 (1996) 7992-7998
100. Pianetti S., Arsura M., Romieu-Mourez R., Coffey R.J., and Sonenshein G.E. Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN. Oncogene 20 (2001) 1287-1299
101. Yang H.Y., Zhou B.P., Hung M.C., and Lee M.H. Oncogenic signals of HER-2/neu in regulating the stability of the cyclin-dependent kinase inhibitor p27. J. Biol. Chem. 275 (2000) 24735-24739
102. Weichselbaum R.R., Hallahan D., Fuks Z., and Kufe D. Radiation induction of immediate early genes: effectors of the radiation-stress response. Int. J. Radiat. Oncol. Biol. Phys. 30 (1994) 229-234
103. Maity A., Kao G.D., Muschel R.J., and McKenna W.G. Potential molecular targets for manipulating the radiation response. Int. J. Radiat. Oncol. Biol. Phys. 37 (1997) 639-653
104. Wolff S. Are radiation-induced effects hormetic?. Science 245 (1989) 575-621
105. Waldman T., Zhang Y., Dillehay L., Yu J., Kinzler K., Vogelstein B., and Williams J. Cell-cycle arrest versus cell death in cancer therapy. Nat. Med. 3 (1997) 1034-1036
106. Schmidt-Ullrich R.K., Dent P., Grant S., Mikkelsen R.B., and Valerie K. Signal transduction and cellular radiation responses. Radiat. Res. 153 (2000) 245-257
107. Wolff S. The adaptive response in radiobiology: evolving insights and implications. Environ. Health Perspect. 106 Suppl. 1 (1998) 277-283
108. Feinendegen L.E. The role of adaptive responses following exposure to ionizing radiation. Hum. Exp. Toxicol. 18 (1999) 426-432
109. Feinendegen L.E. Reactive oxygen species in cell responses to toxic agents. Hum. Exp. Toxicol. 21 (2002) 85-90
110. Jung M., Zhang Y., Lee S., and Dritschilo A. Correction of radiation sensitivity in ataxia telangiectasia cells by a truncated I kappa B-alpha. Science 268 (1995) 1619-1621
111. Wu Z.H., Shi Y., Tibbetts R.S., and Miyamoto S. Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli. Science 311 (2006) 1141-1146
112. Ashburner B.P., Shackelford R.E., Baldwin Jr. A.S., and Paules R.S. Lack of involvement of ataxia telangiectasia mutated (ATM) in regulation of nuclear factor-kappaB (NF-kappaB) in human diploid fibroblasts. Cancer Res. 59 (1999) 5456-5460
113. Li N., Banin S., Ouyang H., Li G.C., Courtois G., Shiloh Y., Karin M., and Rotman G. ATM is required for IkappaB kinase (IKKk) activation in response to DNA double strand breaks. J. Biol. Chem. 276 (2001) 8898-8903
114. Basu S., Rosenzweig K.R., Youmell M., and Price B.D. The DNA-dependent protein kinase participates in the activation of NF kappa B following DNA damage. Biochem. Biophys. Res. Commun. 247 (1998) 79-83
115. Liu J.J., Nakajima K., Hirano T., and Yang-Yen H.F. Activation of Stat3 by v-Src is through a Ras-independent pathway. J. Biomed. Sci. 5 (1998) 446-450
116. Chu W., Gong X., Li Z., Takabayashi K., Ouyang H., Chen Y., Lois A., Chen D.J., Li G.C., Karin M., and Raz E. DNA-PKcs is required for activation of innate immunity by immunostimulatory DNA. Cell 103 (2000) 909-918
117. Raju U., Gumin G.J., and Tofilon P.J. NF kappa B activity and target gene expression in the rat brain after one and two exposures to ionizing radiation. Radiat. Oncol. Investig. 7 (1999) 145-152
118. Baeuml H., Behrends U., Peter R.U., Mueller S., Kammerbauer C., Caughman S.W., and Degitz K. Ionizing radiation induces, via generation of reactive oxygen intermediates, intercellular adhesion molecule-1 (ICAM-1) gene transcription and NF kappa B-like binding activity in the ICAM-1 transcriptional regulatory region. Free Radic. Res. 27 (1997) 127-142
119. Lin P.S., Ho K.C., Sung S.J., and Tsai S. Cytotoxicity and manganese superoxide dismutase induction by tumor necrosis factor-alpha and ionizing radiation in MCF-7 human breast carcinoma cells. Lymphokine Cytokine Res. 12 (1993) 303-308
120. Kiningham K.K., Xu Y., Daosukho C., Popova B., and St. Clair D.K. Nuclear factor kappaB-dependent mechanisms coordinate the synergistic effect of PMA and cytokines on the induction of superoxide dismutase 2. Biochem. J. 353 (2001) 147-156
121. Dumic J., Lauc G., and Flogel M. Expression of galectin-3 in cells exposed to stress-roles of jun and NF-kappaB. Cell. Physiol. Biochem. 10 (2000) 149-158
122. Hallahan D.E., Staba-Hogan M.J., Virudachalam S., and Kolchinsky A. X-ray-induced P-selectin localization to the lumen of tumor blood vessels. Cancer Res. 58 (1998) 5216-5220
123. Iwanaga M., Mori K., Iida T., Urata Y., Matsuo T., Yasunaga A., Shibata S., and Kondo T. Nuclear factor κB dependent induction of γ-glutamylcysteine synthetase by ionizing radiation in T98G human glioblastoma cells. Free Radic. Biol. Med. 24 (1998) 1256-1268
124. Amundson S.A., Do K.T., and Fornace Jr. A.J. Induction of stress genes by low doses of gamma rays. Radiat. Res. 152 (1999) 225-231
125. Maity A., McKenna W.G., and Muschel R.J. The molecular basis for cell cycle delays following ionizing radiation: a review. Radiother. Oncol. 31 (1994) 1-13
126. Almasan A. Cellular commitment to radiation-induced apoptosis. Radiat. Res. 153 (2000) 347-350
127. Muschel R.J., Zhang H.B., Iliakis G., and McKenna W.G. Cyclin B expression in HeLa cells during the G2 block induced by ionizing radiation. Cancer Res. 51 (1991) 5113-5137
128. Metting N.F., and Little J.B. Transient failure to dephosphorylate the cdc2-cyclin B1 complex accompanies radiation-induced G2-phase arrest in HeLa cells. Radiat. Res. 143 (1995) 286-292
129. Kao G.D., McKenna W.G., Maity A., Blank K., and Muschel R.J. Cyclin B1 availability is a rate-limiting component of the radiation-induced G2 delay in HeLa cells. Cancer Res. 57 (1997) 753-758
130. Azzam E.I., de Toledo S.M., Gooding T., and Little J.B. Intercellular communication is involved in the bystander regulation of gene expression in human cells exposed to very low fluences of alpha particles. Radiat. Res. 150 (1998) 497-504
131. Taylor, W.R., Stark, G.R. Regulation of the G2/M transition by p53. Oncogene 0.803-1815.
132. Porter L.A., Cukier I.H., and Lee J.M. Nuclear localization of cyclin B1 regulates DNA damage-induced apoptosis. Blood 101 (2003) 1928-1933
133. Theron T., and Bohm L. Cyclin B1 expression in response to abrogation of the radiation-induced G2/M block in HeLa cells. Cell Prolif. 31 (1998) 49-57
134. Maity A., Hwang A., Janss A., Phillips P., McKenna W.G., and Muschel R.J. Delayed cyclin B1 expression during the G2 arrest following DNA damage. Oncogene 13 (1996) 1647-1657
135. Soria J.C., Jang S.J., Khuri F.R., Hassan K., Liu D., Hong W.K., and Mao L. Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication. Cancer Res. 60 (2000) 4000-4004
136. Hassan K.A., El-Naggar A.K., Soria J.C., Liu D., Hong W.K., and Mao L. Clinical significance of cyclin B1 protein expression in squamous cell carcinoma of the tongue. Clin. Cancer Res. 7 (2001) 2458-2462
137. Hassan K.A., Ang K.K., El-Naggar A.K., Story M.D., Lee J.I., Liu D., Hong W.K., and Mao L. Cyclin B1 overexpression and resistance to radiotherapy in head and neck squamous cell carcinoma. Cancer Res. 62 (2002) 6414-6417
138. Wang X. The expanding role of mitochondria in apoptosis. Genes Dev. 15 (2001) 2922-2933
139. Li P., Nijhawan D., and Wang X. Mitochondrial activation of apoptosis. Cell 116 (2004) S57-S59
140. Adler V., Yin Z., Tew K.D., and Ronai Z. Role of redox potential and reactive oxygen species in stress signaling. Oncogene 18 (1999) 6104-6111
141. Hunt C.R., Sim J.E., Sullivan S.J., Featherstone T., Golden W., Von Kapp-Herr C., Hock R.A., Gomez R.A., Parsian A.J., and Spitz D.R. Genomic instability and catalase gene amplification induced by chronic exposure to oxidative stress. Cancer Res. 58 (1998) 3986-3992
142. Wong G.H. Protective roles of cytokines against radiation: induction of mitochondrial MnSOD. Biochim. Biophys. Acta 1271 (1995) 205-209
143. Sukhatme V.P., Cao X.M., Chang L.C., Tsai-Morris C.H., Stamenkovich D., Ferreira P.C., Cohen D.R., Edwards S.A., Shows T.B., Curran T., et al. A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization. Cell 53 (1988) 37-43
144. Gashler A.L., Swaminathan S., and Sukhatme V.P. A novel repression module, an extensive activation domain, and a bipartite nuclear localization signal defined in the immediate-early transcription factor Egr-1. Mol. Cell. Biol. 13 (1993) 4556-4571
145. Datta R., Taneja N., Sukhatme V.P., Qureshi S.A., Weichselbaum R., and Kufe D.W. Reactive oxygen intermediates target CC(A/T)6GG sequences to mediate activation of the early growth response 1 transcription factor gene by ionizing radiation. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 2419-2422
146. Wei Y.H., Lu C.Y., Lee H.C., Pang C.Y., and Ma Y.S. Oxidative damage and mutation to mitochondrial DNA and age-dependent decline of mitochondrial respiratory function. Ann. N.Y. Acad. Sci. 854 (1998) 155-170
147. Bandy B., and Davison A.J. Mitochondrial mutations may increase oxidative stress: implications for carcinogenesis and aging?. Free Radic. Biol. Med. 8 (1990) 523-539
148. Rhee S.G. Redox signaling: hydrogen peroxide as intracellular messenger. Exp. Mol. Med. 31 (1999) 53-59
149. Das K.C., Lewis-Molock Y., and White C.W. Thiol modulation of TNF alpha and IL-1 induced MnSOD gene expression and activation of NF-kappa B. Mol. Cell. Biochem. 148 (1995) 45-57
150. Grdina D.J., Murley J.S., Kataoka Y., and Calvin D.P. Differential activation of nuclear transcription factor kappaB, gene expression, and proteins by amifostine's free thiol in human microvascular endothelial and glioma cells. Semin. Radiat. Oncol. 12 (2002) 103-111
151. Murley J.S., Kataoka Y., Cao D., Li J.J., Oberley L.W., and Grdina D.J. Delayed radioprotection by NFkappaB-mediated induction of Sod2 (MnSOD) in SA-NH tumor cells after exposure to clinically used thiol-containing drugs. Radiat. Res. 162 (2004) 536-546
152. Wong G.H., Elwell J.H., Oberley L.W., and Goeddel D.V. Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 58 (1989) 923-931
153. Siemankowski L.M., Morreale J., and Briehl M.M. Antioxidant defenses in the TNF-treated MCF-7 cells: selective increase in MnSOD. Free Radic. Biol. Med. 26 (1999) 919-924
154. Oberley L.W., St Clair D.K., Autor A.P., and Oberley T.D. Increase in manganese superoxide dismutase activity in the mouse heart after X-irradiation. Arch. Biochem. Biophys. 254 (1987) 69-80
155. Summers R.W., Maves B.V., Reeves R.D., Arjes L.J., and Oberley L.W. Irradiation increases superoxide dismutase in rat intestinal smooth muscle. Free Radic. Biol. Med. 6 (1989) 261-270
156. Epperly M., Bray J., Kraeger S., Zwacka R., Engelhardt J., Travis E., and Greenberger J. Prevention of late effects of irradiation lung damage by manganese superoxide dismutase gene therapy. Gene Ther. 5 (1998) 196-208
157. Epperly M.W., Defilippi S., Sikora C., Gretton J., Kalend A., and Greenberger J.S. Intratracheal injection of manganese superoxide dismutase (MnSOD) plasmid/liposomes protects normal lung but not orthotopic tumors from irradiation. Gene Ther. 7 (2000) 1011-1018
158. Williams M.D., Van Remmen H., Conrad C.C., Huang T.T., Epstein C.J., and Richardson A. Increased oxidative damage is correlated to altered mitochondrial function in heterozygous manganese superoxide dismutase knockout mice. J. Biol. Chem. 273 (1998) 28510-28515
159. Hussain S.P., Amstad P., He P., Robles A., Lupold S., Kaneko I., Ichimiya M., Sengupta S., Mechanic L., Okamura S., Hofseth L.J., Moake M., Nagashima M., Forrester K.S., and Harris C.C. p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis. Cancer Res. 64 (2004) 2350-2356
160. Wan X.S., Devalaraja M.N., and St Clair D.K. Molecular structure and organization of the human manganese superoxide dismutase gene. DNA Cell Biol. 13 (1994) 1127-1136
161. Duttaroy A., Parkes T., Emtage P., Kirby K., Boulianne G.L., Wang X., Hilliker A.J., and Phillips J.P. The manganese superoxide dismutase gene of Drosophila: structure, expression, and evidence for regulation by MAP kinase. DNA Cell Biol. 16 (1997) 391-399
162. Xu Y., Kiningham K.K., Devalaraja M.N., Yeh C.C., Majima H., Kasarskis E.J., and St Clair D.K. An intronic NF-kappaB element is essential for induction of the human manganese superoxide dismutase gene by tumor necrosis factor-alpha and interleukin-1beta. DNA Cell Biol. 18 (1999) 709-722